A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and Placebo

OBJECTIVES: Selective cyclooxygenase (COX)-2 inhibitors are effective analgesic and anti-inflammatory agents with improved gastrointestinal safety and tolerability compared with traditional NSAIDs. However, data from long-term, placebo-controlled studies have shown an increased risk of thrombotic ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannon, Christopher P, Chen, Cong, Curtis, Sean P, Viscusi, John, Ahmed, Tuli, DiBattiste, Peter M
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817438/
https://www.ncbi.nlm.nih.gov/pubmed/20157362
http://dx.doi.org/10.1111/j.1753-5174.2007.00002.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817438/
https://www.ncbi.nlm.nih.gov/pubmed/20157362
http://dx.doi.org/10.1111/j.1753-5174.2007.00002.x

Ejemplares similares